The rapidly increasing interest within research to monitor and diagnose psychiatric and neurological diseases more efficiently in people’s daily lives (in-the-wild) and in the laboratory (in-the-lab) requires new IT infrastructure effectively combining various types of sensors.
Background
The rapidly increasing interest within research to monitor and diagnose psychiatric and neurological diseases more efficiently in people’s daily lives (in-the-wild) and in the laboratory (in-the-lab) requires new IT infrastructure effectively combining various types of sensors. The yearly cost of these diseases in Europe alone is estimated at Euro 800 billion of which Euro 500 billion is related to psychiatric diseases.
Today no integrated in-the-wild and in-the-lab platform exist that empowers researchers to conduct biometric healthcare research in an efficient way. Hence, the IT task in itself is massive and in many cases become prohibitive for research being conducted with the loss of innovation and efficiency gains as a consequence.
Objectives
The aim of this project is to develop the first integrated in-the-wild and in-the-lab biometric healthcare research platform designed specifically to the needs of the researchers. The platform will extend iMotions' world-leading general-purpose in- the-lab platform, which has gained significant traction both within behavioral research and in healthcare research despite not currently optimized for this purpose. In this project, iMotions is teaming up with researcher in CACHET involving both IT researchers and physicians to build and test this new platform. DTU will design the software architecture for in-the-wild data sampling and do advanced data analysis. Two clinical studies will be done at Zealand University Hospital (Epilepsy) and the Gillberg Neuropsychiatry Centre (Autism).